We are live on
!
Find out more
LP
Longaeva Partners Portfolio holdings
AUM
$2.7B
1-Year Est. Return
37.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.4%
1 Year Est. Return
+37.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
+$1.51B
(+127%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
64.98%
Top 10 Holdings %
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$80.3M |
| 2 |
Boston Scientific
BSX
|
+$76.6M |
| 3 |
KeyCorp
KEY
|
+$62.3M |
| 4 |
Goldman Sachs
GS
|
+$60.3M |
| 5 |
MMED
MiniMed Group Inc
MMED
|
+$52.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAI
Caris Life Sciences
CAI
|
+$40.7M |
| 2 |
Becton Dickinson
BDX
|
+$25.5M |
| 3 |
TPG
TPG
|
+$23.9M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$22.6M |
| 5 |
Edwards Lifesciences
EW
|
+$22.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.18% |
| 2 | Healthcare | 16.78% |
| 3 | Technology | 12.09% |
| 4 | Industrials | 6.84% |
| 5 | Consumer Discretionary | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERO
151
Grupo Aeromexico SAB de CV
AERO
$2.18B
| $2.1M | 0.08% |
150,000
| – | – |
|
152
Rockwell Automation
ROK
$51.4B
| $2.03M | 0.08% |
+5,659
| New | +$2.23M |
|
|
USAR
153
USA Rare Earth Inc
USAR
$3.46B
| $1.89M | 0.07% |
+124,687
| New | +$2.42M |
|
|
SEPN
154
Septerna Inc
SEPN
$1.49B
| $1.79M | 0.07% |
74,567
+24,665
| +49% | +$648K |
|
155
DigitalOcean
DOCN
$14.4B
| $1.73M | 0.06% |
+20,219
| New | +$1.27M |
|
156
Rani Therapeutics
RANI
$95.6M
| $1.71M | 0.06% |
2,329,459
+216,024
| +10% | +$276K |
|
157
American Airlines Group
AAL
$9.58B
| $1.69M | 0.06% |
+157,172
| New | +$2.08M |
|
|
OFRM
158
Once Upon a Farm PBC
OFRM
$631M
| $1.64M | 0.06% |
+100,000
| New | +$2.06M |
|
159
BrightSpring Health Services
BTSG
$14.3B
| $1.63M | 0.06% |
+38,307
| New | +$1.54M |
|
|
MH
160
McGraw Hill
MH
$1.9B
| $1.63M | 0.06% |
118,944
-131,307
| -52% | -$1.84M |
|
161
Everspin Technologies
MRAM
$354M
| $1.52M | 0.06% |
+172,774
| New | +$1.9M |
|
|
CLYM
162
Climb Bio
CLYM
$735M
| $1.49M | 0.06% |
+217,768
| New | +$1.26M |
|
|
BETA
163
Beta Technologies Inc
BETA
$4.2B
| $1.41M | 0.05% |
95,925
-253,683
| -73% | -$5.2M |
|
164
Roku
ROKU
$21.1B
| $1.38M | 0.05% |
+14,608
| New | +$1.42M |
|
165
Benitec Biopharma
BNTC
$394M
| $1.33M | 0.05% |
125,000
-165,000
| -57% | -$1.91M |
|
166
Western Union
WU
$2.57B
| $1.29M | 0.05% |
+148,203
| New | +$1.4M |
|
167
JB Hunt Transport Services
JBHT
$27.1B
| $1.26M | 0.05% |
+5,941
| New | +$1.27M |
|
168
Edgewise Therapeutics
EWTX
$4.39B
| $1.16M | 0.04% |
+36,931
| New | +$1.06M |
|
|
SERV
169
Serve Robotics
SERV
$409M
| $1.09M | 0.04% |
+129,367
| New | +$1.4M |
|
170
M&T Bank
MTB
$36.2B
| $1.09M | 0.04% |
+5,261
| New | +$1.13M |
|
171
Summit Therapeutics
SMMT
$10.9B
| $1.09M | 0.04% |
+57,282
| New | +$926K |
|
172
United Parcel Service
UPS
$97.6B
| $1.09M | 0.04% |
+11,030
| New | +$1.18M |
|
173
BWX Technologies
BWXT
$16B
| $1M | 0.04% |
+4,909
| New | +$997K |
|
174
TransDigm Group
TDG
$69.2B
| $977K | 0.04% |
+843
| New | +$1.11M |
|
|
VOYG
175
Voyager Technologies
VOYG
$1.5B
| $965K | 0.04% |
+41,273
| New | +$1.18M |
|
Similar funds
GIA
HCM
CI
LSA
HC
SCM
BCM
NB
Longaeva Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Longaeva Partners deployed $1.75B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.
- Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
- Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
- Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
- Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
- Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
- Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
- Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.
Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.